Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest update is out from Trinity Biotech ( (TRIB) ).
Trinity Biotech has filed a prospectus supplement as part of its registration statement with the U.S. Securities and Exchange Commission to offer and sell up to $2,306,000 worth of American Depositary Shares. Each ADS represents 20 A Ordinary Shares, and the offering is facilitated through an at-the-market agreement with Craig-Hallum Capital Group LLC. This move potentially strengthens Trinity Biotech’s capital position and underscores its strategic efforts to tap into the U.S. market.
More about Trinity Biotech
Trinity Biotech plc is a public limited company incorporated in Ireland, operating in the biotechnology industry. The company focuses on the development and sale of diagnostic products and is known for its American Depositary Shares (ADSs) offerings.
YTD Price Performance: -62.15%
Average Trading Volume: 176,750
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $9.21M
Learn more about TRIB stock on TipRanks’ Stock Analysis page.
